Role of the UGT2B17 deletion in exemestane pharmacogenetics.

about

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

Item

http://www.wikidata.org/entity/Q38769425

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

@en

type

Item

label

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

@en

prefLabel

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

@en

P1476

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

@en

P2093

C C Baird

http://www.w3.org/2001/XMLSchema#string

C Truica

http://www.w3.org/2001/XMLSchema#string

G Chen

http://www.w3.org/2001/XMLSchema#string

K Leitzel

http://www.w3.org/2001/XMLSchema#string

P Lazarus

http://www.w3.org/2001/XMLSchema#string

S Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Arsenic in urine and drinking water

Cancer statistics, 2015

History of aromatase: saga of an important biological mediator and therapeutic target

Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes

Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism

The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer

Cancer statistics, 2016

Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.

Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

Aromatase inhibitors for breast cancer in postmenopausal women.

P2888

tpj.2017.18

P31

scholarly article

P356

10.1038/TPJ.2017.18

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085560215

http://www.w3.org/2001/XMLSchema#string

P698

28534527

http://www.w3.org/2001/XMLSchema#string

P932

5700874

http://www.w3.org/2001/XMLSchema#string

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

about

Role of the UGT2B17 deletion in exemestane pharmacogenetics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P932